ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage

被引:149
作者
Soejima, K [1 ]
Matsumoto, M
Kokame, K
Yagi, H
Ishizashi, H
Maeda, H
Nozaki, C
Miyata, T
Fujimura, Y
Nakagaki, T
机构
[1] Chemo Sero Therapeut Res Inst, Res Dept 1, Kumamoto 8691298, Japan
[2] Nara Med Univ, Dept Blood Transfus Med, Nara, Japan
[3] Natl Cardiovasc Ctr, Res Inst, Osaka, Japan
[4] Nara Med Univ, Dept Hlth Sci, Nara, Japan
关键词
D O I
10.1182/blood-2003-03-0908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A severe lack of von Willebrand factor-cleaving protease (VWF-CP) activity can cause thrombotic thrombocytopenic purpura (TTP). This protease was recently identified as a member of the ADAMTS family, ADAMTS-13. It consists of a pre-proregion, a metalloprotease domain, a disintegrin-like domain, a thrombospondin type-1 motif (Tsp1), a cysteine-rich domain, a spacer domain, additional Tsp1 repeats, and CUB domains. To explore the structural and functional relationships of ADAMTS-13, we prepared here 13 sequential COOH-terminal truncated mutants and a single-point mutant (ArgGlyAsp [RGD] to ArgGlyGlu [RGE] in the cysteine-rich domain) and compared the activity of each mutant with that of the wild-type protein. The results revealed that the truncation of the cysteine-rich/spacer domains caused a remarkable reduction in VWF-CP activity. We also prepared immunoglobulin G (IgG) fractions containing inhibitory auto-antibodies against ADAMTS-13 from plasma from 3 patients with acquired TTP, and we performed mapping of their epitopes using the aforementioned mutants. The major epitopes of these antibodies were found to reside within the cysteine-rich/spacer domains. These results suggest that the ADAMTS-13 cysteine-rich/spacer domains are essential for VWF-CP activity. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3232 / 3237
页数:6
相关论文
共 40 条
[11]   Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Lämmle, B .
BLOOD, 1998, 91 (08) :2839-2846
[12]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[13]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234
[14]   Partial amino acid sequence of purified von Willebrand factor-cleaving protease [J].
Gerritsen, HE ;
Robles, R ;
Lämmle, B ;
Furlan, M .
BLOOD, 2001, 98 (06) :1654-1661
[15]   SYNTHESIS OF VONWILLEBRAND FACTOR BY CULTURED HUMAN ENDOTHELIAL CELLS [J].
JAFFE, EA ;
HOYER, LW ;
NACHMAN, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (05) :1906-1909
[16]   Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocytopenic purpura [J].
Kinoshita, S ;
Yoshioka, A ;
Park, YD ;
Ishizashi, H ;
Konno, M ;
Funato, M ;
Matsui, T ;
Titani, K ;
Yagi, H ;
Matsumoto, M ;
Fujimura, Y .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 74 (01) :101-108
[17]   Mutations and common polymorphisms in ADAMTS13 gene responsiblefor von Willebrand factor-cleaving protease activity [J].
Kokame, K ;
Matsumoto, M ;
Soejima, K ;
Yagi, H ;
Ishizashi, H ;
Funato, M ;
Tamai, H ;
Konno, M ;
Kamide, K ;
Kawano, Y ;
Miyata, T ;
Fujimura, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11902-11907
[18]   ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type I motifs and its spacing region [J].
Kuno, K ;
Matsushima, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13912-13917
[19]   Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura [J].
Levy, GG ;
Nichols, WC ;
Lian, EC ;
Foroud, T ;
McClintick, JN ;
McGee, BM ;
Yang, AY ;
Siemieniak, DR ;
Stark, KR ;
Gruppo, R ;
Sarode, R ;
Shurin, SB ;
Chandrasekaran, V ;
Stabler, SP ;
Sabio, H ;
Bouhassira, EE ;
Upshaw, JD ;
Ginsburg, D ;
Tsai, HM .
NATURE, 2001, 413 (6855) :488-494
[20]  
Matsumoto M, 2000, BLOOD, V96, p636A